Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 6.2M | Sales 2022 | 1.5M | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -25M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.23% | 21.96B | |
-8.58% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |